Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
Recruiting
Phase 1
Phase 2
Interventional Study
PARKINSON DISEASE (Disorder)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- U: The Mind Company · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head.
Participants will use the device at home for 13 minutes each weekday (Monday through Friday) for 3 weeks, then be monitored for another 3 weeks wi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults 18-80 years with confirmed diagnosis of Parkinson's Disease
* Hoehn \& Yahr stages 1-4
* Stable medication regimen for 4+ weeks prior to enrollment
* Reliable internet access and telehealth capability
* Ability to provide informed consent
* Willingness to comply with tr…
Contacts
No contact information available.